These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Reinforced cytotoxicity of lymphokine-activated killer cells toward glioma cells by transfection with the tumor necrosis factor-alpha gene. Tashiro T; Yoshida J; Mizuno M; Sugita K J Neurosurg; 1993 Feb; 78(2):252-6. PubMed ID: 8421207 [TBL] [Abstract][Full Text] [Related]
7. Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines. Wang MH; Flad HD; Böhle A; Chen YQ; Ulmer AJ Immunol Lett; 1991 Mar; 27(3):191-7. PubMed ID: 2060970 [TBL] [Abstract][Full Text] [Related]
8. Regulation of NK cells through the 80-kDa TNFR (CD120b). Mason AT; McVicar DW; Smith CA; Young HA; Ware CF; Ortaldo JR J Leukoc Biol; 1995 Aug; 58(2):249-55. PubMed ID: 7543923 [TBL] [Abstract][Full Text] [Related]
9. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms. Bean P; Mazumder A Immunobiology; 1992 Jun; 185(1):63-77. PubMed ID: 1398742 [TBL] [Abstract][Full Text] [Related]
10. High release of tumor necrosis factor alpha, interferon gamma and interleukin-6 by adherent lymphokine-activated killer cells phenotypically derived from T cells. Koberda J; Bergmann L; Mitrou PS; Hoelzer D J Cancer Res Clin Oncol; 1991; 117(5):425-30. PubMed ID: 1909699 [TBL] [Abstract][Full Text] [Related]
11. [Effects of pretreating target cells with iron citrate on cytolysis, mediated by tumor necrosis factor and lymphokine-activated killer cells]. Kalinina AR; Sadovnikov VB; Vodianik MA; Pashkevich AP Dokl Akad Nauk; 1994 Jan; 334(2):237-40. PubMed ID: 8167581 [No Abstract] [Full Text] [Related]
12. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity. Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440 [TBL] [Abstract][Full Text] [Related]
13. Target cell membrane modification and susceptibility to lymphokine activated killer cell mediated lysis. I. Trinitrophenyl has no effect on murine normal cells and tumors. Lefor AT J Surg Res; 1991 Oct; 51(4):316-23. PubMed ID: 1921371 [TBL] [Abstract][Full Text] [Related]
14. Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1. Eckert K; Grünberg E; Immenschuh P; Garbin F; Kreuser ED; Maurer HR J Cancer Res Clin Oncol; 1997; 123(8):420-8. PubMed ID: 9292704 [TBL] [Abstract][Full Text] [Related]
15. Suppression of lymphokine-activated killer induction by neutrophils. Shau HY; Kim A J Immunol; 1988 Dec; 141(12):4395-402. PubMed ID: 3264311 [TBL] [Abstract][Full Text] [Related]
16. Immunoregulatory effects of the herba Epimediia glycoside icariin. He W; Sun H; Yang B; Zhang D; Kabelitz D Arzneimittelforschung; 1995 Aug; 45(8):910-3. PubMed ID: 7575760 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils. Shau HY; Golub SH J Immunol; 1989 Aug; 143(3):1066-72. PubMed ID: 2787346 [TBL] [Abstract][Full Text] [Related]
19. [Role of the neutrophils in the pathogenesis of malignant growth]. Kashulina AP; Tereshchenko IP Eksp Onkol; 1985; 7(6):3-9. PubMed ID: 3910404 [TBL] [Abstract][Full Text] [Related]
20. Successful combination immunotherapy for the generation in vivo of antitumor activity with anti-CD3, interleukin 2, and tumor necrosis factor alpha. Yang SC; Fry KD; Grimm EA; Roth JA Arch Surg; 1990 Feb; 125(2):220-5. PubMed ID: 2137327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]